Heart alert: blood test may catch immunotherapy side effects early
NCT ID NCT06007274
First seen Apr 25, 2026 · Last updated May 04, 2026 · Updated 2 times
Summary
This study looked at 300 cancer patients treated with immune checkpoint inhibitors to see if measuring troponin (a heart protein) in the blood can help detect serious heart problems early. The goal was to find out if this monitoring helps prevent heart attacks, strokes, or other major heart events without forcing patients to stop their cancer treatment. The study was completed and used past medical records to compare outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Mutualiste Montsouris
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.